Connect
← Return to What advances to expect in prostate cancer treatment in coming years?
Discussion
What advances to expect in prostate cancer treatment in coming years?
Prostate Cancer | Last Active: 2 minutes ago | Replies (10)Comment receiving replies
Jeff: thanks a million for sharing this extensive list of emerging prostate cancer detection and treatment approaches at various stages of development, clinical trials, and implementation.
Given my situation and my substantial pathological and biological risk of BCR, I am particularly interested in developments that could provide earlier molecular detection of recurrence, much more sensitive imaging at lower PSA levels, increasingly precise local treatments that minimize collateral damage to healthy tissues, and more selective systemic therapies.
I’ll review the materials in detail and will ask questions or add comments as I learn more. This is exactly the kind of information I was hoping we could share in this group so that we can all stay informed about what may be coming.
Replies to "@jeffmarc Jeff: thanks a million for sharing this extensive list of emerging prostate cancer detection and..."
@soli There is promising research into how to more accurately predict which patients will find that their cancers metastasize. The researchers feel their new classification system will eventually replace the Gleason grading system in importance. So far they have validated their system using the extensive pathology available from prostate glands that have been removed, by analyzing the long term outcomes that result after surgery. They are hoping to be able to do as well with biopsy pathology. .
UCSF has a recording of the webinar they hosted:
https://www.urotoday.com/video-lectures/a-journal-club-for-patients-with-prostate-cancer/video/mediaitem/4452-unfavorable-histology-classification-aims-to-reduce-unnecessary-treatment-journal-club-jesse-mckenney-jane-nguyen-cornelia-ding.html
A Q&A afterward was recorded as well: https://www.urotoday.com/video-lectures/a-journal-club-for-patients-with-prostate-cancer/video/mediaitem/4453-unfavorable-histology-classification-aims-to-reduce-unnecessary-treatment-discussion.html
Their published research: https://pubmed.ncbi.nlm.nih.gov/38828674/
Connect
@soli
I try to keep up with the latest trials related to castrate resistance people, Since it keeps coming back, I know, I will need something when what I’m on now stops working. I want something better than a PARP inhibitor.
I keep adding new things to my list. I’m glad it helps people that are looking for the latest new developments.
If anybody find something new and interesting that I didn’t list, please put in a link to it.